Junctional Epidermolysis Bullosa 2 (JEB2)
Gene or Region: LAMA3
Reference Variant: no change in LAMA3
Mutant Variant: 6,589 bp deletion
Affected Breeds: American Saddlebred
Research Confidence: High - Findings reproduced multiple studies
Explanation of Results: jeb2/jeb2 = homozygous for Junctional Epidermolysis Bullosa Type 2, trait expressed jeb2/n = heterozygous for Junctional Epidermolysis Bullosa Type 2, carrier n/n = no variant detected
JEB2 in American Saddlebreds: Understanding Junctional Epidermolysis Bullosa & LAMA3 Mutation
Junctional Epidermolysis Bullosa 2 (JEB2), also known as red foot disease or hairless foal syndrome, results in the inability to produce the proteins needed to keep the skin on the body. Affected foals exhibit symptoms within days of birth, including blisters at the pressure points, detachment of the hooves, and oral ulcers. As there is no treatment, affected foals are humanely euthanized. JEB2 is an autosomal recessive condition, thus a horse must inherit two copies of the allele (jeb2/jeb2) to show any signs. Horses with only one copy of the variant (jeb2/n) are known as carriers due to their ability to produce affected foals.
Gene Information
LAMA3 is a subunit of a key component of basement membranes. Mutations in other subunits of this complex have been shown to result in JEB2 in many human populations. This particular mutation is a 6,589 bp deletion spanning exons 24-27 that disrupts the normal amino acid sequence, resulting in a truncated protein.
Carrier frequency: estimated at slightly more than 5% in American Saddlebreds
References
K. T. Graves, P. J. Henney and R. B. Ennis. Partial deletion of the LAMA3 gene is responsible for hereditary junctional epidermolysis bullosa in the American Saddlebred Horse. (2008) Animal Genetics, 40, 35–41
More Horse Health
Equine Herpes Virus Type 1 & Induced Myeloencephalopathy
Equine herpesviruses are DNA viruses that are found in most horses all over the world, often without any serious side effects. Following infection of Equine Herpesvirus Type 1 (EHV-1) some horses then suffer Equine Herpesvirus Myeloencephalopathy (EHM), which is is accompanied by serious and sometimes fatal neurological effects. EHM in horses can have serious neurological symptoms on affected horses.
Equine Metabolic Syndrome / Laminitis Risk
Equine Metabolic Syndrome (EMS) is a wide-spread issue in the horse population. Primarily characterized by hyperinsulinemia (excess insulin circulating in the blood in relation to glucose levels), this metabolic disorder is often present in obese horses and ponies and can be challenging to diagnose as it can be misdiagnosed as "Cushing's" (a pituitary disfunction).
Equine Recurrent Uveitis Risk and Severity
Equine Recurrent Uveitis (ERU) is the most common cause of blindness in horses, affecting about 3-15% of the horse population worldwide. Characterized by episodes of inflammation of the middle layer of the eye, Equine Recurrent Uveitis in horses leads to the development of cataracts, glaucoma and eventually complete loss of vision.